% | $
Quotes you view appear here for quick access.

Synergy Pharmaceuticals, Inc. Message Board

  • biotech_chairman_and_ceo biotech_chairman_and_ceo Jan 24, 2013 6:00 AM Flag

    Not many retail customers are short Synergy, that wouldn't be prudent. Not many institutional investors are long either (16%) owned by them.

    It is going to be awhile as they will need to see more progress before they enter positions. Probably two years, and one dilution. Why own now? Wait for the new shares to be issued?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Why own now? LOL

      They will be gone in less than a year. $25/share. Maybe more.

      Sentiment: Strong Sell

    • let's take your premise and build it out so folks understand the fallacy of your argument

      SGYP has $30MM cash on hand, and you claim they need to run operations for 2 year. So let's assume a heavy clinical burden In that time frame, therefore they would complete 1 or 2 additional phase III trials for plecanatide plus a phase II for SP-333.

      That would roughly require a total of $60MM in clinical operations plus $5-$10MM in SG&A and FTE expenses. Let's call it $70MM for the runway you propose and since we are speculating let's also say they add an extra $20MM as buffer for a rainy day.

      Based on your premise they would need to raise $60MM in addition to the $30MM in the bank. That works out to be about 10 million more shares issued at $6/share (worse case). even in this scenario the company is significantly undervalued!

      Sentiment: Strong Buy

    • Does this mean your're not done yet? Guess I'll find out soon. My best.

9.12+0.53(+6.17%)Jul 31 4:00 PMEDT